As per our latest research, the global Vaginitis Therapeutics market size stood at USD 3.41 billion in 2024, reflecting a robust landscape driven by rising awareness and increasing prevalence of vaginal infections. The market is projected to expand at a CAGR of 6.9% during the forecast period, reaching approximately USD 6.26 billion by 2033. This growth is primarily attributed to the escalating incidence of vaginitis, the introduction of advanced therapeutics, and a growing emphasis on women’s health worldwide.
https://growthmarketreports.co....m/report/vaginitis-t